LKFT:NASDAQ
Lakefront Biotherapeutics NV - ADR
$29.32
arrow_downward
-0.64%(-0.19) 1D
$29.32
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT...
Open
$29.75
High
$29.90
Low
$29.09
Mkt. cap
1.90B
Avg. vol.
294.84K
Volume
0.00
52-wk high
$32.41
52-wk low
$25.68
Beta
0.24
Shares outstanding
65.90M
No. of employees
196
Open
$29.75
High
$29.90
Low
$29.09
Mkt. cap
1.90B
Avg. vol.
294.84K
Volume
0.00
52-wk high
$32.41
52-wk low
$25.68
Beta
0.24
Shares outstanding
65.90M
No. of employees
196
News stories
From web sources and news partners
Stock Titan
·
8 hours ago
At €25.99 a share, Lakefront Biotherapeutics (LKFT) repurchased €3.05M of its stock.
TipRanks
·
8 hours ago
Lakefront Biotherapeutics Buys Back 117,437 Shares in Ongoing Repurchase Program
GlobeNewswire
·
9 hours ago
Acquisition of Own Shares
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV - ADR
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com